Acquainting veterinary students with careers in the pharmaceutical industry by McGregor, Douglas D. et al.
Research and Education Reports
Acquainting Veterinary Students with Careers
in the Pharmaceutical Industry
Douglas D. McGregor gDavid R. Fraser gMichelle L. Haven gGerard J. Hickey
ABSTRACT
Careers in the pharmaceutical industry were revealed in modules facilitated by senior scientists from companies that sponsor
the Cornell Leadership Program for Veterinary Students. One module was structured as a series of interviews for different
positions in industry, the other as a competition between hypothetical companies created by students. The interview-based
module stimulated wide-ranging discussion of the activities and responsibilities of veterinarians employed in a discovery-
intensive pharmaceutical firm and of the characteristics such companies seek in prospective employees, from both
professional and personal perspectives. The second module explored the drug discovery and development process from the
perspective of animal-health companies that are competitors in the market for animal health care products. The exercise
provided insights into the manner in which companies discover new chemical entities, screen candidate drugs, allocate
resources, and pursue the development of products through testing, licensing, and distribution.
BACKGROUND
Cornell University hosts an annual Leadership Program
for Veterinary Students. The program targets students
who have the ability and commitment to broadly influence
their profession. The initiative combines independent,
faculty-guided research; vocational counseling; and group
learning modules calculated to develop creativity, critical
thinking, effective communication, and teamwork skills.
All are student-directed exercises that encourage broad
participation and enable students to participate actively in
their own education.
1
Two of the group learning modules are subjects of this
report. Both highlight career opportunities for veterinary
graduates in the pharmaceutical industry. In the following
narrative we comment on the evolution of the modules,
their current structure, and their perceived value in
informing students about employment opportunities in
mature, discovery-based firms whose principal purposes
are to develop and market products for the treatment or
prevention of animal diseases.
CAREERS IN INDUSTRY
The typical veterinary curriculum leaves little room for
students to acquire knowledge about discovery-based
careers. Nowhere is that deficiency more conspicuous than
in careers in business, and the pharmaceutical industry in
particular. An effort to address the problem within the
context of the leadership program began in 1990, the first
year the program was offered. Scientists from Merck were
invited to address the students. These visitors explained the
range of employment opportunities for veterinarians in
a major research-oriented pharmaceutical firm; they
contrasted the activities of industrial scientists with the
responsibilities incumbent on academic faculty. In addition
to the presentations at Cornell, participating scholars visited
the research facilities of Merck in Rahway, New Jersey, and
the company’s nearby Branchburg farm.
The presentations were well received, but their passive
format limited the depth of understanding that students
were able to gain from the experience. Participation was
limited to questions and occasional comments from
students who had work experience in an industrial setting.
The field visit to Rahway and to Merck’s research farm
provided greater scope for student involvement; but this
significant benefit was offset by a time commitment that
could not be readily accommodated within the already busy
schedule of the 10-week program.
Beginning in 2004, the ‘‘Merck module’’ was modified with
a view to engaging students more actively. The revised
event is structured as a series of mock interviews in which
students are quizzed about their motivation and aptitude
for veterinary staff positions. In advance of the meeting,
and as a framework for discussion, students are given three
typical and different position descriptions and the dossiers
of three hypothetical candidates. Resource materials con-
sisting of scientific articles based on plausible experiences
of the prospective applicants and information about the
responsibilities and expectations of successful candidates
are included in a program workbook. Avideodisc recording
of events connected with the previous year’s program is
provided for the students’ convenience and to illustrate how
the module is structured.
The students divide themselves into three groups, each
representing a candidate for one of the three positions.
The individual groups are obliged to submit a letter of
application for the position they select. The letters are
reviewed by three staff scientists or service specialists at
Merck. On the day of the meeting, the facilitators interview
the groups sequentially. Students not involved in this phase
of the proceedings observe the performance of their fellow
students and reflect on the nature of the facilitators’
questions until they in turn assume the role of ‘‘applicant.’’
The module has achieved its intended purpose. Much of the
information that emerged in the passive presentations
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between students and facilitators. But the interviews have
additional advantages over the original model. First, they
are riveting experiences, in the sense that students cannot
anticipate what questions they will be asked or when their
comments will be solicited. Second, the new format ensures
universal participation, since each student is obliged to
respond to facilitator questions and to raise questions of
his or her own. Third, and arguably most importantly,
the revised structure provides students with practical
experience of the interview processes—experience that
will serve them well later in their careers.
DRUG DESIGN AND DEVELOPMENT
An entirely different approach was used in the second
exercise, which grew out of an in-house training program
at Pfizer Animal Health. This module illustrates opportu-
nities and challenges connected with the discovery,
development, and marketing of pharmaceuticals. The
objective is to acquaint students with the drug-discovery
process. Prominence is given to how candidate drugs are
selected; how testing procedures are conducted; the
requirements for licensing products, and practical matters
connected with the marketing and use of pharmaceuticals
and biologicals. All focus on striving for efficient processes
and working within a budget in a competitive environment.
Special emphasis is placed on career opportunities for
veterinarians at each stage in the process.
The Pfizer module is organized as a competition.
In preparing for it, the students divide themselves into
three teams, each representing a pharmaceutical company
attempting to launch a product for the treatment of
osteoarthritis in dogs. Each team chooses a company name
and assigns its members to groups concerned with the
biology and chemistry of drugs, drug safety and metabo-
lism, manufacturing, testing of drugs both in vitro and
in patients, licensing of products, marketing, and the
provision of technical services to practitioners and their
clients. In advance of the formal meeting, each team
prepares a one-page outline for the development and
marketing of their product. The plans are reviewed by
three facilitators at Pfizer, who comment on the teams’
strategies and draw attention to issues requiring clarifica-
tion or further explanation.
On the day of the module, the teams present their plans to
the three facilitators and the students at large. Questions
arising during the presentations are considered privately
by the individual groups during a recess. Thereafter, the
groups reassemble to present their revised plans or
defend their initial approaches. At the conclusion of the
meeting, the facilitators comment on the three plans and
on principles and practices that drive the drug-discovery
process. These include, but are not limited to, resource
allocation and scientific, economic, and ethical issues
connected with the development and marketing of
pharmaceuticals.
The drug-discovery module has not been modified
significantly during the seven years that it has been
an important feature of the leadership program. Students
find the exercise informative and challenging. Their
enthusiasm is reflected in the creativity they demonstrate
in devising a product-development plan and defending
their individual strategies. From a learning perspective,
the value of the module lies in its capacity to
illustrate careers for veterinarians in a discovery-based
pharmaceutical firm.
DISCUSSION
Industry offers a wide range of employment opportunities
for veterinarians, but remarkably few veterinary graduates
choose that career option.
2,3 By virtue of their training in
comparative biology and animal diseases, veterinarians are
uniquely qualified to manage large colonies of experimental
animals required for basic biomedical research and
the testing and licensing of pharmaceuticals. Moreover,
veterinarians with advanced training in pathology or
clinical studies are well prepared to function as specialists
in comparative pathology, toxicology, and drug evaluation.
These and other positions in the pharmaceutical industry
offer attractive financial benefits and sensitivity to the
work–life balance needs of employees and their families.
Yet remarkably few veterinary graduates follow these
career paths. Data published by the American Veterinary
Medical Association indicate that less than 2.4% of
US veterinary graduates realize careers in commercial
enterprises.
4 However, those who do choose this
option readily find employment in major pharmaceutical
firms, service companies, and discovery-based
organizations whose origins can be traced to the remarkable
advances made in biotechnology during the past several
decades.
The foregoing considerations raise the question of why
veterinarians are not attracted in larger numbers to these
diverse and professionally rewarding occupations. One
possibility is that the opportunities are not often portrayed
to veterinary students in a realistic and compelling manner.
A notable exception is the curriculum at Virginia–Maryland
Regional College of Veterinary Medicine (VMRC),
which has adopted a flexible course that enables students
to tailor their education to their vocational interests and
career aspirations.
5 The Public/Corporate Veterinary
Medicine track at VMRC focuses on aspects of veterinary
science that are especially relevant to individuals aspiring
to a career in industry. Other colleges may provide similar
information through course electives and vocational
options.
6 These experiences emphasize skills that are
important for industrial scientists and veterinary service
specialists to acquire. Nevertheless, it could be argued that
exercises presented from an academic perspective may not
capture the ‘‘corporate culture’’ as effectively as facilitator-
aided modules conducted by scientists who have industrial
experience and presently occupy positions well suited to
veterinary graduates.
However that may be, the desire to portray industrial
careers for veterinarians in a more informative manner
provided the impetus for developing the two modules
reported here. Both were organized by senior scientists at
pharmaceutical companies who had personal experience
and supervisory responsibilities for individuals employed
in the discovery-based vocations and service positions
to which veterinary graduates are naturally attracted.
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advantages and limitations of careers pursued in an
industry setting.
The module designed by scientists at Merck compares
discovery-based careers in a major pharmaceutical firm
with the activities pursued by academic faculty. Initially, the
subject was addressed passively, in a lecture format
followed by an informal period of questions and discussion.
The presentations were informative, but the discussion was
uneven and usually dominated by a few members of the
audience. In an effort to involve students more actively,
the authors restructured the module as a series of inter-
views. Students within individual groups are now asked
questions regarding their motivation and qualifications for
the positions for which they have applied. The facilitators
not only answer the questions but explain how the
discovery process is managed in a commercial enterprise.
In the course of the exchanges, the facilitators also
emphasize the characteristics that a corporation seeks in
potential employees. These include, but are not limited to,
knowledge, creativity, a good work ethic, interpersonal
skills, and the capacity of employees to work effectively as
members of a team.
Halfway through the individual interviews, the roles of
interrogator and responder are reversed, thereby enabling
students to explore different aspects of industrial careers.
Students are eager to learn about job security, the compen-
sation they can expect, and the capacity of employees to
remain purposefully involved in projects as products move
through development, through the approval process, and
into the marketplace.
The interview model has several advantages over the
original presentation format. First, students have
the opportunity to consider relevant materials prior to the
meeting and to organize their thoughts on the topics to be
discussed. The interviews are also successful in engaging
the entire student group. Finally, students gain practical
experience in preparing themselves for an interview.
Notable in this connection is the advice facilitators offer
for constructing an application letter. Emphasis is placed
on how individuals should illustrate their qualifications
for employment and their knowledge of the company
concerned.
The second module was modeled on a program
developed for Pfizer employees. The exercise encourages
creativity and effective communication while simulta-
neously promoting the development of teamwork skills.
The Pfizer module reveals practical aspects of drug
development that may be infrequently addressed in the
conventional veterinary curriculum. Topics include resource
allocation within a pharmaceutical company; considerations
that bear upon the selection of candidate drugs; the
influence of competitive pressures; and outcomes that
lead to the advancement or termination of a project.
The module illustrates the importance of teamwork and
flexibility on the part of employees; requirements that
must be satisfied in licensing drugs and biologicals;
and strategies for the management of products in the
marketplace. It also inspires students to explore existing
knowledge about a major veterinary disease problem
and to face the challenge of designing an effective
therapeutic agent.
SUMMARY
The Cornell Leadership Program for Veterinary Students
gives prominence to two student-directed modules that
highlight careers in the pharmaceutical industry. The
modules were developed jointly by the program organizers
and senior scientists from two corporate sponsors of the
program, Merck and Pfizer. The exercises use different
formats, but both provide insights into the operations
of discovery-based companies while highlighting the
skills and personal characteristics that such companies
seek in prospective employees. Students find the modules
thought-provoking and welcome the opportunity they
afford to establish useful contacts with scientists in the
participating companies.
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